Table 2 Distribution of the COVID-19 in women’s HIV harm reduction centers
From: Challenges of the COVID-19 pandemic on women’s HIV harm reduction centers: a mixed-methods study
Variables | N(%)a | |
|---|---|---|
Duration of treatment) Days) (Mean ± SD) b | 8.1 ± 5.7 | |
Infected with COVID-19 | Yes | 165(38.4) |
No | 265(61.6) | |
The number of times of infecting with COVID-19 | Once | 129(78.2) |
Twice | 27(16.4) | |
Three times | 9(5.4) | |
Quarantine place | Home | 102(61.8) |
Night shelter | 32(19.4) | |
Hospital | 31(18.8) | |
History of receiving the COVID-19 vaccine | Yes | 365(84.9) |
No | 65(15.1) | |
The number of times of vaccination | Once | 53(14.5) |
Twice | 201(55.1) | |
Three times | 100(27.4) | |
Four times | 11(3.0) | |
The place of vaccination | City | 244(66.8) |
Women’s HIV harm reduction centers | 108(29.6) | |
Hospital | 5(1.4) | |
Clinic | 6(1.7) | |
Prison | 2(0.5) | |
Conducting a diagnostic test for COVID-19 | Yes | 319(74.2) |
No | 111(25.8) | |
Type of diagnostic test for COVID-19 | Nasal swab | 245(76.8) |
Blood test | 17(5.3) | |
Lung X-ray | 13(4.1) | |
Nasal swab and lung x-ray | 12(3.8) | |
Nasal swab and Blood test | 32(10.0) | |